Member Exclusive

Congress Looks to Move BIOSECURE Act

Key Takeaways

  • A bill to limit US exposure to Chinese biotech firms has been introduced in the House and Senate.
  • BIOSECURE would cast a wide net, including by prohibiting the federal government from entering into contracts with US companies that do business with designated Chinese biotech firms.
  • The bill could find itself in the annual defense package as lawmakers negotiate a path forward.

This content is exclusive to USCBC members only.

Sign In


Join USCBC to read further.

YOU'RE INVITED
Forecast 2025

Forecast 2025